Bibliografías temáticas / Multiple Sclerosis, MRI / Artículos de revistas
Siga este enlace para ver otros tipos de publicaciones sobre el tema: Multiple Sclerosis, MRI.

Artículos de revistas sobre el tema "Multiple Sclerosis, MRI"

Autor: Grafiati
Publicado: 10 de marzo de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Multiple Sclerosis, MRI".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Bermel, Robert A. y Robert J. Fox. "MRI IN MULTIPLE SCLEROSIS". CONTINUUM: Lifelong Learning in Neurology 16 (octubre de 2010): 37–57. http://dx.doi.org/10.1212/01.con.0000389933.77036.14.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Inglese, Matilde y Maria Petracca. "MRI in multiple sclerosis". Current Opinion in Neurology 31, n.º 3 (junio de 2018): 249–55. http://dx.doi.org/10.1097/wco.0000000000000559.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Filippi, Massimo, Paolo Preziosa y Maria A. Rocca. "MRI in multiple sclerosis". Current Opinion in Neurology 31, n.º 4 (agosto de 2018): 386–95. http://dx.doi.org/10.1097/wco.0000000000000572.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Ceccarelli, Antonia, Rohit Bakshi y Mohit Neema. "MRI in multiple sclerosis". Current Opinion in Neurology 25, n.º 4 (agosto de 2012): 402–9. http://dx.doi.org/10.1097/wco.0b013e328354f63f.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Simon, Jack H. "MRI in Multiple Sclerosis". Physical Medicine and Rehabilitation Clinics of North America 16, n.º 2 (mayo de 2005): 383–409. http://dx.doi.org/10.1016/j.pmr.2005.01.012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Radü, E. W., N. Mueller-Lenke, A. Thoeni, A. Palatini y K. Bendfeldt. "MRI in Multiple Sclerosis". Neuroradiology Journal 22, n.º 1_suppl (septiembre de 2009): 43–50. http://dx.doi.org/10.1177/19714009090220s109.

Texto completo
Resumen
The diagnosis of Multiple Sclerosis (MS) is based on clinical findings that are characterized by sudden neurological deficits in different parts of the CNS. Dissemination of lesions in space and time is the basic criterion. MRI can demonstrate most precisely any changes in the water content of brain tissue thus making it a very sensitive diagnostic tool to detect inflammatory processes like MS plaques. The following will briefly summarize the diagnostic features and procedures and will assess the appearance of typical MS lesions, their localization and configuration, which are essential for diagnosis and follow up examinations. It will propose the preferred sequences and technical parameters for standardized baseline examinations and follow-ups.
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Choi, Min Yun, Chang Hyo Sol, Choon Phill Chung, Byung Soo Kim y Byung Ho Park. "MRI findinga of multiple sclerosis". Journal of the Korean Radiological Society 29, n.º 4 (1993): 627. http://dx.doi.org/10.3348/jkrs.1993.29.4.627.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Lynch, S. G., J. W. Rose, W. Smoker y J. H. Petajan. "MRI in familial multiple sclerosis". Neurology 40, n.º 6 (1 de junio de 1990): 900. http://dx.doi.org/10.1212/wnl.40.6.900.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Filippi, Massimo y Maria A. Rocca. "Conventional MRI in Multiple Sclerosis". Journal of Neuroimaging 17 (abril de 2007): 3S—9S. http://dx.doi.org/10.1111/j.1552-6569.2007.00129.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Rocca, Maria A. y Massimo Filippi. "Functional MRI in Multiple Sclerosis". Journal of Neuroimaging 17 (abril de 2007): 36S—41S. http://dx.doi.org/10.1111/j.1552-6569.2007.00135.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

James, Philip B. "MRI, monosclerosis, and multiple sclerosis". Lancet 359, n.º 9315 (abril de 2002): 1436. http://dx.doi.org/10.1016/s0140-6736(02)08377-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Alroughani, R. "Advances in multiple sclerosis MRI". Journal of the Neurological Sciences 405 (octubre de 2019): 33. http://dx.doi.org/10.1016/j.jns.2019.10.092.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Rovaris, M., A. Gass, R. Bammer, S. J. Hickman, O. Ciccarelli, D. H. Miller y M. Filippi. "Diffusion MRI in multiple sclerosis". Neurology 65, n.º 10 (21 de noviembre de 2005): 1526–32. http://dx.doi.org/10.1212/01.wnl.0000184471.83948.e0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Petracca, Maria, Lazar Fleysher, Niels Oesingmann y Matilde Inglese. "Sodium MRI of multiple sclerosis". NMR in Biomedicine 29, n.º 2 (6 de abril de 2015): 153–61. http://dx.doi.org/10.1002/nbm.3289.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Edwards, MK, MR Farlow y JC Stevens. "Multiple sclerosis: MRI and clinical correlation". American Journal of Roentgenology 147, n.º 3 (septiembre de 1986): 571–74. http://dx.doi.org/10.2214/ajr.147.3.571.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Zhang, Yunyan. "MRI Texture Analysis in Multiple Sclerosis". International Journal of Biomedical Imaging 2012 (2012): 1–7. http://dx.doi.org/10.1155/2012/762804.

Texto completo
Resumen
Multiple sclerosis (MS) is a complicated disease characterized by heterogeneous pathology that varies across individuals. Accurate identification and quantification of pathological changes may facilitate a better understanding of disease pathogenesis and progression and help identify novel therapies for MS patients. Texture analysis evaluates interpixel relationships that generate characteristic organizational patterns in an image, many of which are beyond the ability of visual perception. Given its promise detecting subtle structural alterations texture analysis may be an attractive means to evaluate disease activity and evolution. It may also become a new tool to assess therapeutic efficacy if technique issues are resolved and pathological correlates are further confirmed. This paper describes the concept, strategies, and considerations of MRI texture analysis; summarizes applications of texture analysis in MS as a measure of tissue integrity and its clinical relevance; then discusses potentially future directions of texture analysis in MS.
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Filippi, Massimo y Federica Agosta. "Magnetization Transfer MRI in Multiple Sclerosis". Journal of Neuroimaging 17 (abril de 2007): 22S—26S. http://dx.doi.org/10.1111/j.1552-6569.2007.00132.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Rovaris, Marco y Massimo Filippi. "Diffusion Tensor MRI in Multiple Sclerosis". Journal of Neuroimaging 17 (abril de 2007): 27S—30S. http://dx.doi.org/10.1111/j.1552-6569.2007.00133.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Lycklama, Geert, Alan Thompson, Massimo Filippi, David Miller, Christ Polman, Franz Fazekas y Frederik Barkhof. "Spinal-cord MRI in multiple sclerosis". Lancet Neurology 2, n.º 9 (septiembre de 2003): 555–62. http://dx.doi.org/10.1016/s1474-4422(03)00504-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Filippi, M. y M. A. Rocca. "MRI and cognition in multiple sclerosis". Neurological Sciences 31, S2 (16 de julio de 2010): 231–34. http://dx.doi.org/10.1007/s10072-010-0367-5.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Muccilli, Alexandra, Estelle Seyman y Jiwon Oh. "Spinal Cord MRI in Multiple Sclerosis". Neurologic Clinics 36, n.º 1 (febrero de 2018): 35–57. http://dx.doi.org/10.1016/j.ncl.2017.08.009.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Filippi, M., M. Absinta y M. A. Rocca. "Future MRI tools in multiple sclerosis". Journal of the Neurological Sciences 331, n.º 1-2 (agosto de 2013): 14–18. http://dx.doi.org/10.1016/j.jns.2013.04.025.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Banwell, B., M. Shroff, J. M. Ness, D. Jeffery, S. Schwid y B. Weinstock-Guttman. "MRI features of pediatric multiple sclerosis". Neurology 68, Issue 16, Supplement 2 (16 de abril de 2007): S46—S53. http://dx.doi.org/10.1212/01.wnl.0000259406.09052.75.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Sormani, M. P., M. Filippi, N. De Stefano, G. Ebers y M. Daumer. "MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS". Neurology 73, n.º 22 (30 de noviembre de 2009): 1932–33. http://dx.doi.org/10.1212/wnl.0b013e3181bd6b8f.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Tenser, R. B., G. C. Ebers y M. Daumer. "MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS". Neurology 73, n.º 22 (30 de noviembre de 2009): 1933–34. http://dx.doi.org/10.1212/wnl.0b013e3181bd6baa.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Reider-Groswasser, I., E. Kott, J. Benmair, M. Huberman, Y. Machtey y I. Gelernter. "MRI parameters in multiple sclerosis patients". Neuroradiology 30, n.º 3 (junio de 1988): 219–23. http://dx.doi.org/10.1007/bf00341832.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Huws, R., A. P. W. Shubsachs y P. J. Taylor. "Hypersexuality, Fetishism and Multiple Sclerosis". British Journal of Psychiatry 158, n.º 2 (febrero de 1991): 280–81. http://dx.doi.org/10.1192/bjp.158.2.280.

Texto completo
Resumen
Hypersexuality and fetishism appeared in a patient with multiple sclerosis whose MRI scan showed frontal and temporal lesions. The hypersexuality may have been the presenting symptom of the multiple sclerosis.
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Theodorsdottir, Asta, Pia Veldt Larsen, Helle Hvilsted Nielsen, Zsolt Illes y Mads Henrik Ravnborg. "Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis". Acta Neurologica Scandinavica 145, n.º 3 (19 de noviembre de 2021): 332–47. http://dx.doi.org/10.1111/ane.13554.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

Filippi, Massimo, Paolo Preziosa, Brenda L. Banwell, Frederik Barkhof, Olga Ciccarelli, Nicola De Stefano, Jeroen J. G. Geurts et al. "Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines". Brain 142, n.º 7 (17 de junio de 2019): 1858–75. http://dx.doi.org/10.1093/brain/awz144.

Texto completo
Resumen
Abstract MRI has improved the diagnostic work-up of multiple sclerosis, but inappropriate image interpretation and application of MRI diagnostic criteria contribute to misdiagnosis. Some diseases, now recognized as conditions distinct from multiple sclerosis, may satisfy the MRI criteria for multiple sclerosis (e.g. neuromyelitis optica spectrum disorders, Susac syndrome), thus making the diagnosis of multiple sclerosis more challenging, especially if biomarker testing (such as serum anti-AQP4 antibodies) is not informative. Improvements in MRI technology contribute and promise to better define the typical features of multiple sclerosis lesions (e.g. juxtacortical and periventricular location, cortical involvement). Greater understanding of some key aspects of multiple sclerosis pathobiology has allowed the identification of characteristics more specific to multiple sclerosis (e.g. central vein sign, subpial demyelination and lesional rims), which are not included in the current multiple sclerosis diagnostic criteria. In this review, we provide the clinicians and researchers with a practical guide to enhance the proper recognition of multiple sclerosis lesions, including a thorough definition and illustration of typical MRI features, as well as a discussion of red flags suggestive of alternative diagnoses. We also discuss the possible place of emerging qualitative features of lesions which may become important in the near future.
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Lattanzi, Simona, Francesco Logullo, Paolo Di Bella, Mauro Silvestrini y Leandro Provinciali. "Multiple sclerosis, solitary sclerosis or something else?" Multiple Sclerosis Journal 20, n.º 14 (22 de mayo de 2014): 1819–24. http://dx.doi.org/10.1177/1352458514535129.

Texto completo
Resumen
Background: Inflammatory demyelinating diseases of the central nervous system represent a wide spectrum of entities and their classification cannot currently be regarded complete. Objective: Our aim is to describe a series of patients presenting with progressive myelopathy associated to a single demyelinating lesion of the spinal cord. Methods: We identified the patients affected by chronic progressive spinal cord dysfunction related to a single spinal cord lesion not satisfying the diagnostic criteria for any of the currently defined diseases. Results: Seven females and one male were included. The median age at onset of symptoms was 53 years (range 42–68) and the median follow-up was 8 years (range 5–12). Brain and spinal magnetic resonance imaging (MRI) scans detected only one single, circumscribed, T2 hyperintense, non-longitudinally extensive lesion at level of cervico-medullary junction or cervical cord, in the absence of Gadolinium enhancement or swelling. Cerebrospinal fluid (CSF) examination displayed neither oligoclonal bands nor raised IgG index. A response to immunosuppressive agents was observed in some of the patients. Serial control brain and spinal MRI did not reveal accumulation of new lesions. Conclusion: New entities or variants should be included among the inflammatory demyelinating diseases of the central nervous system, and their characterization may have relevant prognostic and treatment implications.
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Comi, Giancarlo, Letizia Leocani, Stefania Medaglini, Tiziana Locatelli, Vittorio Martinelli, Giuseppe Santuccio y Paolo Rossi. "Measuring evoked responses in multiple sclerosis". Multiple Sclerosis Journal 5, n.º 4 (agosto de 1999): 263–67. http://dx.doi.org/10.1177/135245859900500412.

Texto completo
Resumen
Evoked potentials (EPs) have been widely utilised in Multiple Sclerosis (MS) patients to demonstrate the involvement of sensory and motor pathways. Their diagnostic value is based on the ability to reveal clinically silent lesions and to objectivate the central nervous system damage in patients who complain frequently of vague and indefinite disturbances which frequently occurs in the early phases of the disease. The advent of magnetic resonance imaging (MRI) techniques has greatly reduced the clinical utilisation of EPs, which is not fully justifiable, as the information provided by EPs are quite different from those provided by MRI. The abnormalities of evoked responses reflect the global damage of the evoked nervous pathway and are significantly correlated with the clinical findings, while the vast majority of MRI lesions are not associated to symptoms and signs. Transversal and longitudinal studies have demonstrated that EP changes in MS are more strictly related to disability than MRI lesion burden. On the contrary, MRI is more sensitive than EPs in revealing the disease activity. Evoked responses modifications observed in MS are not disease-specific; moreover longitudinal studies showed latency and morphology changes of evoked responses not always related to clinical changes. Such a dissociation can be explained both by technical factors and by subclinical disease activity. To reduce the negative impact of technical aspects, only reproducible parameters of the evoked responses should be used to monitor disease evolution and therapeutic interventions.
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Alroughani, Raed y Bassem Yamout. "Multiple Sclerosis". Seminars in Neurology 38, n.º 02 (abril de 2018): 212–25. http://dx.doi.org/10.1055/s-0038-1649502.

Texto completo
Resumen
AbstractMultiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune etiology, mediated by activated T cells with evolving evidence of a significant contribution from B cells and cells of the innate immune system. The disease is thought to be due to a complex interaction between different genetic and environmental factors. The prevalence of MS is rising all over the world, due on one hand to earlier diagnosis and prolonged survival, and on the other to a true increase in incidence of the disease. The diagnosis of MS remains clinical despite recent advances in diagnostics and relies on demonstrating dissemination in space and time while excluding alternative diagnoses. The Mc Donald diagnostic criteria, with their recent 2017 revision, are currently widely accepted in the MS community. Although no cure is yet available, many disease-modifying therapies (DMTs) have shown different levels of efficacy in preventing relapses, accumulation of lesions on magnetic resonance imaging (MRI), and disability progression. Current treatment strategies include gradual escalation based on clinical and radiological criteria that determine treatment response, or initial induction with high efficacy DMTs especially in patients with an early aggressive course.
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Granziera, Cristina, Jens Wuerfel, Frederik Barkhof, Massimiliano Calabrese, Nicola De Stefano, Christian Enzinger, Nikos Evangelou et al. "Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis". Brain 144, n.º 5 (1 de mayo de 2021): 1296–311. http://dx.doi.org/10.1093/brain/awab029.

Texto completo
Resumen
Abstract Quantitative MRI provides biophysical measures of the microstructural integrity of the CNS, which can be compared across CNS regions, patients, and centres. In patients with multiple sclerosis, quantitative MRI techniques such as relaxometry, myelin imaging, magnetization transfer, diffusion MRI, quantitative susceptibility mapping, and perfusion MRI, complement conventional MRI techniques by providing insight into disease mechanisms. These include: (i) presence and extent of diffuse damage in CNS tissue outside lesions (normal-appearing tissue); (ii) heterogeneity of damage and repair in focal lesions; and (iii) specific damage to CNS tissue components. This review summarizes recent technical advances in quantitative MRI, existing pathological validation of quantitative MRI techniques, and emerging applications of quantitative MRI to patients with multiple sclerosis in both research and clinical settings. The current level of clinical maturity of each quantitative MRI technique, especially regarding its integration into clinical routine, is discussed. We aim to provide a better understanding of how quantitative MRI may help clinical practice by improving stratification of patients with multiple sclerosis, and assessment of disease progression, and evaluation of treatment response.
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Miller, DH. "Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force". Multiple Sclerosis Journal 1, n.º 6 (junio de 1996): 335–38. http://dx.doi.org/10.1177/135245859600100610.

Texto completo
Resumen
In relapsing-remitting and secondary progressive multiple sclerosis (MS), MRI activity on monthly brain scans is a sensitive primary outcome measure in short term exploratory treatment trials. Because conventional MRI findings have a limited correlation with disability, the primary outcome in definitive trials should be clinical, although MRI is useful in providing an index of pathological progression. In trials aimed at preventing evolution from a clinically isolated syndrome to MS, MRI findings should be used in the entry criteria. The likely pathological substrates of irreversible disability are demyelination and axonal loss. Putative MR markers for these pathologies appear to relate more closely to disability than conventional MRI findings. Further technical developments should lead to improved quantitation, pathological specificity and clinical correlations.
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Díaz-Sánchez, María, S. Mayra Gómez-Moreno, M. Asunción Morales-Otal, Ana Ramos-González y Julián Benito-León. "Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes". Multiple Sclerosis Journal 16, n.º 5 (1 de marzo de 2010): 576–80. http://dx.doi.org/10.1177/1352458510362996.

Texto completo
Resumen
The MRI Barkhof—Tintoré criteria have proved to be highly specific for predicting conversion to clinically definite multiple sclerosis in patients with clinically isolated syndromes (CIS), but lacked an optimal sensitivity. In order to improve the accuracy of early multiple sclerosis diagnosis, new imaging criteria have been proposed by Swanton et al. We aimed to evaluate the accuracy of both MRI criteria for dissemination in space to predict conversion from CIS to clinically definite multiple sclerosis. We studied 79 CIS patients with baseline MRI performed within the first 3 months after onset. The sensitivity and specificity of both MRI criteria to predict conversion to clinically definite multiple sclerosis were analysed. The time to develop clinically definite multiple sclerosis from CIS onset, according to each imaging criteria, was studied by Kaplan—Meier survival curves. The overall conversion rate was 75.7% with a median follow-up of 57 months. Barkhof— Tintoré’s criteria showed a sensitivity of 71.9% and a specificity of 77.2%. Swanton’s criteria had a sensitivity of 91.2% and a specificity of 68.1%. Both MRI criteria identified CIS patients with higher risk and faster conversion to clinically definite multiple sclerosis. Swanton’s criteria are simpler and more sensitive than Barkhof—Tintoré‘s criteria, with a slight decrease in specificity. These results reinforce their use in multiple sclerosis diagnosis.
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Gasperini, Claudio, Luca Prosperini, Mar Tintoré, Maria Pia Sormani, Massimo Filippi, Jordi Rio, Jacqueline Palace et al. "Unraveling treatment response in multiple sclerosis". Neurology 92, n.º 4 (26 de diciembre de 2018): 180–92. http://dx.doi.org/10.1212/wnl.0000000000006810.

Texto completo
Resumen
Over the last few decades, the improved diagnostic criteria, the wide use of MRI, and the growing availability of effective pharmacologic treatments have led to substantial advances in the management of multiple sclerosis (MS). The importance of early diagnosis and treatment is now well-established, but there is still no consensus on how to define and monitor response to MS treatments. In particular, the clinical relevance of the detection of minimal MRI activity is controversial and recommendations on how to define and monitor treatment response are warranted. An expert panel of the Magnetic Resonance Imaging in MS Study Group analyzed and discussed published studies on treatment response in MS. The evolving concept of no evidence of disease activity and its effect on predicting long-term prognosis was examined, including the option of defining a more realistic target for daily clinical practice: minimal evidence of disease activity. Advantages and disadvantages associated with the use of MRI activity alone and quantitative scoring systems combining on-treatment clinical relapses and MRI active lesions to detect treatment response in the real-world setting were also discussed. While most published studies on this topic involved patients treated with interferon-β, special attention was given to more recent studies providing evidence based on treatment with other and more efficacious oral and injectable drugs. Finally, the panel identified future directions to pursue in this research field.
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

HASHIGUCHI, Shuji, Nozomi OGASAWARA, Hideki MINE y Yasunori KAWACHI. "Multiple Sclerosis with Caudate Lesions on MRI." Internal Medicine 40, n.º 4 (2001): 358–62. http://dx.doi.org/10.2169/internalmedicine.40.358.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Schippling, Sven. "MRI for multiple sclerosis diagnosis and prognosis". Neurodegenerative Disease Management 7, n.º 6s (noviembre de 2017): 27–29. http://dx.doi.org/10.2217/nmt-2017-0038.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Millichap, J. Gordon. "Cognitive Impairment in Multiple Sclerosis and MRI". Pediatric Neurology Briefs 25, n.º 1 (1 de enero de 2011): 7. http://dx.doi.org/10.15844/pedneurbriefs-25-1-9.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

Jasek, Łukasz, Janusz Śmigielski y Małgorzata Siger. "Late onset multiple sclerosis — multiparametric MRI characteristics". Neurologia i Neurochirurgia Polska 54, n.º 3 (30 de junio de 2020): 265–71. http://dx.doi.org/10.5603/pjnns.a2020.0036.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Jalal, Hicham, Amine El Masloumi, Anass Chehboun, Meryem Ouali Idrissi y Najat Cherif Idrissi El Ganouni. "Role of MRI in Childhood Multiple Sclerosis". Scholars Journal of Medical Case Reports 08, n.º 02 (20 de febrero de 2020): 251–53. http://dx.doi.org/10.36347/sjmcr.2020.v08i02.042.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Wolinsky, JS. "MRI aspects of secondary progressive multiple sclerosis". Multiple Sclerosis Journal 8, n.º 1_suppl (septiembre de 2002): 85–87. http://dx.doi.org/10.1177/1352458502008001177.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Wolinsky, J. S. "MRI aspects of secondary progressive multiple sclerosis". Multiple Sclerosis Journal 8, n.º 1 (febrero de 2002): 85–87. http://dx.doi.org/10.1177/135245850200800118.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Fazekas, F. y A. Thompson. "New MRI techniques and “aggressive” multiple sclerosis". Multiple Sclerosis Journal 15, n.º 3 (19 de enero de 2009): 283–84. http://dx.doi.org/10.1177/1352458509102997.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Seze, J., S. Delalande, E. Michelin, J. Y. Gauvrit, M. A. Mackowiak, D. Ferriby, T. Stojkovic, L. Defebvre, J. P. Pruvo y P. Vermersch. "Brain MRI in late-onset multiple sclerosis". European Journal of Neurology 12, n.º 4 (abril de 2005): 241–44. http://dx.doi.org/10.1111/j.1468-1331.2004.01103.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Agosta, Federica y Massimo Filippi. "MRI of Spinal Cord in Multiple Sclerosis". Journal of Neuroimaging 17 (abril de 2007): 46S—49S. http://dx.doi.org/10.1111/j.1552-6569.2007.00137.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Louapre, C. "Conventional and advanced MRI in multiple sclerosis". Revue Neurologique 174, n.º 6 (junio de 2018): 391–97. http://dx.doi.org/10.1016/j.neurol.2018.03.009.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Chen, J. J., F. Carletti, V. Young, D. Mckean y G. Quaghebeur. "MRI differential diagnosis of suspected multiple sclerosis". Clinical Radiology 71, n.º 9 (septiembre de 2016): 815–27. http://dx.doi.org/10.1016/j.crad.2016.05.010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Poser, CharlesM. "MRI of spinal cord in multiple sclerosis". Lancet 341, n.º 8851 (abril de 1993): 1025. http://dx.doi.org/10.1016/0140-6736(93)91115-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Guttmann, Charles R. G., Dominik S. Meier y Christopher M. Holland. "Can MRI reveal phenotypes of multiple sclerosis?" Magnetic Resonance Imaging 24, n.º 4 (mayo de 2006): 475–81. http://dx.doi.org/10.1016/j.mri.2005.12.038.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías sobre el tema "Multiple Sclerosis, MRI" para otros tipos de fuentes:
Tesis
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía